Actively Recruiting
Impact of Dietary Guidance and Probiotics in the Treatment of Endometriosis and Irritable Bowel Syndrome in Women
Led by University of Sao Paulo · Updated on 2025-09-02
74
Participants Needed
1
Research Sites
206 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients with endometriosis are 2 to 3 times more likely to develop Irritable Bowel Syndrome (IBS) than women without the condition. IBS presents symptoms similar to those of intestinal and deep EDT, leading to diagnostic errors and delays in identifying such comorbidities. Diets have shown positive effects on symptoms in women with both conditions, supporting the theory of a similar pathophysiology. The investigators goal is to examine how dietary practices and probiotic use affect chronic pelvic pain in patients with both comorbidities.
CONDITIONS
Official Title
Impact of Dietary Guidance and Probiotics in the Treatment of Endometriosis and Irritable Bowel Syndrome in Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women between 18 and 50 years of age who wish to participate in the clinical trial
- Willingness to voluntarily participate in the study and accept randomization to any of the three treatment arms
- Participating exclusively in this clinical trial during the study period
- Signing the Informed Consent Form (ICF) approved by the Research Ethics Committee and CONEP
You will not qualify if you...
- Chronic, severe, or uncompensated clinical conditions such as malnutrition (BMI <18), insulin-dependent diabetes, uncontrolled hypertension, lung diseases, hematologic and liver diseases, advanced chronic kidney disease, metabolic disorders, and immunosuppression
- Gastrointestinal conditions causing IBS-like symptoms such as inflammatory bowel disease, microscopic colitis, celiac disease, and lactose intolerance
- Endometriosis requiring surgical treatment during the study
- Severe eating disorders like bulimia, anorexia nervosa, and binge-eating disorder
- Chronic use of medications affecting probiotics, microbiota, or disease progression in the last 6 months
- Regular consumption of healthy or restrictive diets more than four days a week
- Altered stool parasitological examination
- Inability to take oral medication
- Pregnancy or lactation
- History of alcohol or drug dependence
- Smoking within the last three years
- Cognitive impairment or mental state preventing cooperation with investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Letícia Ferracini Lenharo Hayashi
Catanduva, São Paulo, Brazil, 15800-050
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here